Published in J Thromb Haemost on November 01, 2004
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack. J Thromb Haemost (2008) 1.07
Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients. J Transl Med (2015) 0.79
Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome. Am J Cardiol (2010) 0.77
Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs. Ther Adv Drug Saf (2015) 0.75
Influence of genetic variations on levels of inflammatory markers of healthy subjects at baseline and one week after clopidogrel therapy; results of a preliminary study. Int J Mol Sci (2013) 0.75
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. BMJ (2000) 4.21
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med (2000) 3.90
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation (2002) 3.63
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study. BMJ (2001) 2.85
von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J (2002) 2.66
Seasonal variations in coronary heart disease. QJM (1999) 2.65
Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol (2003) 2.63
Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation (2001) 2.43
The potential impact of patient self-referral on mortality in acute myocardial infarction. Q J Med (1993) 2.43
Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J (2004) 2.18
Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the 'Utstein Style'. Resuscitation (1993) 2.17
Thrombolysis in myocardial infarction. BMJ (1994) 2.13
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J (1999) 2.08
Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study. Eur Heart J (2000) 2.08
Acute exercise and markers of endothelial injury in peripheral arterial disease. Eur J Vasc Endovasc Surg (1997) 2.07
Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med (2008) 2.06
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol (2001) 1.96
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation (2001) 1.78
Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol (1997) 1.72
Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction. Eur Heart J (1984) 1.72
Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J (1989) 1.70
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. J Thromb Haemost (2007) 1.69
Beta endorphin release in patients after spontaneous and provoked acute myocardial ischaemia. Br Heart J (1992) 1.67
Sex differences in outcome following community-based cardiopulmonary arrest. Eur Heart J (2000) 1.64
Role of endogenous opioids and catecholamines in vasovagal syncope. Eur Heart J (1996) 1.63
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies. Eur Heart J (2004) 1.62
The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years. Eur Heart J (1993) 1.60
Efficacy of out of hospital defibrillation by ambulance technicians using automated external defibrillators. The Heartstart Scotland Project. Resuscitation (1992) 1.60
Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol (1991) 1.59
Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am Heart J (2004) 1.59
Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J (1996) 1.59
The time of onset and severity of acidosis in myocardial ischaemia. J Mol Cell Cardiol (1980) 1.50
Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia (2004) 1.46
Acute hepatitis after parenteral amiodarone administration. Br Heart J (1988) 1.46
Congenital and acquired long QT syndrome. Eur Heart J (2000) 1.45
Fetal corticotrophin-releasing hormone mRNA, but not phosphatidylserine-exposing microparticles, in maternal plasma are associated with factor VII activity in pre-eclampsia. J Thromb Haemost (2007) 1.43
When is it futile for ambulance personnel to initiate cardiopulmonary resuscitation? BMJ (1995) 1.42
Cardiac pacing. Lancet (1997) 1.41
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J (1995) 1.38
Increased fetal hemoglobin in insulin-treated diabetes mellitus contributes to the imprecision of glycohemoglobin measurements. Clin Chem (1993) 1.35
Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol (1996) 1.29
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27
Acute effects of diuretics on potassium exchange, mechanical function and the action potential in rabbit myocardium. Clin Sci Mol Med Suppl (1978) 1.25
The electrophysiological and mechanical effects of 2,3-butane-dione monoxime and cytochalasin-D in the Langendorff perfused rabbit heart. Exp Physiol (2004) 1.25
Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J (2004) 1.24
QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J (1994) 1.24
Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failure. Cardiovasc Res (2000) 1.19
Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy. Cardiovasc Res (1992) 1.18
Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol (1999) 1.17
Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol (1997) 1.17
Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost (2009) 1.16
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry (2002) 1.16
Neuroendocrine activation after acute myocardial infarction. Br Heart J (1988) 1.16
Neuroendocrine changes in acute myocardial infarction. Am J Med (1988) 1.16
Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet (1993) 1.14
The causative rhythm in out-of-hospital cardiac arrests witnessed by the emergency medical services in the Heartstart Scotland Project. Resuscitation (1994) 1.11
A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing. Br Heart J (1987) 1.11
Presentation, management, and outcome of out of hospital cardiopulmonary arrest: comparison by underlying aetiology. Heart (2003) 1.11
Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women. Atherosclerosis (2009) 1.10
Acute treatment of torsades de pointes with amiodarone: proarrhythmic and antiarrhythmic association of QT prolongation. Am Heart J (1990) 1.09
Dispersion of ventricular repolarization and refractory period. Cardiovasc Res (2001) 1.09
C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol (2001) 1.08
Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol (1997) 1.08
Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy. Pharmacol Ther (1999) 1.08
Heart rate variability in left ventricular hypertrophy. Br Heart J (1995) 1.07
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack. J Thromb Haemost (2008) 1.07
Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men. QJM (2008) 1.07
Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost (2007) 1.06
Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Circulation (1998) 1.05
Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace (2002) 1.05
Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study. Arterioscler Thromb Vasc Biol (2000) 1.05
C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies. Arterioscler Thromb Vasc Biol (2004) 1.03
Catheter tip pH electrodes for continuous intravascular recording. J Med Eng Technol (1980) 1.02
Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis (1993) 1.02
Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events. Thromb Haemost (1999) 1.01
Response of heart rate to a roller coaster ride. BMJ (1990) 1.01